Raised Liver Enzymes and a Low White Blood Cell Count
Raised liver enzymes and low white blood cells are two separate conditions that have several mild to severe causes and indications. Both conditions can manifest from the same disease or its treatments. Your physician will typically address each issue separately while trying to determine the underlying factor.
If you are experiencing serious medical symptoms, seek emergency treatment immediately.
Raised Liver Enzymes
The liver participates in several metabolic, digestive and detoxification processes. It produces and secretes various enzymes that have functions throughout the body. Liver function tests measure the amount of liver enzymes and proteins in the blood. Increased levels of enzymes can indicate inflammation or infection damage to the liver, according to MayoClinic.com 2. Common causes of elevated liver enzymes include over-the-counter and prescription medications, such as acetaminophen and cholesterol-lowering statins; obesity; hepatitis A, B, and C; alcohol consumption; heart disease; and nonalcoholic fatty liver disease 2. However, MayoClinic.com also notes that elevated liver enzymes do not signify a serious complication most of the time 2.
- The liver participates in several metabolic, digestive and detoxification processes.
- Increased levels of enzymes can indicate inflammation or infection damage to the liver, according to MayoClinic.com 2.
Low White Blood Cells
Low Platelet Count & Fatty Liver Disease
Learn More
White blood cells participate in immunity, protecting the body from infection, disease and foreign bodies. Chronically low white blood cells can indicate serious complications with your bone marrow, the tissue responsible for producing white and red blood cells, according to MedlinePlus, an online resource of the National Institutes of Health. These include viral infections, autoimmune disease and cancers, such as leukemia and lymphoma.
Liver Disease
MedlinePlus reports that certain diseases that cause damage to liver cells can cause low white blood cells. These include hepatitis and fatty liver disease. Cirrhosis also contributes to low white blood cells, according to the University of Maryland Medical Center 4. In addition, any liver disease causes elevated liver enzymes 2.
Chemotherapy
How to Treat a Salicylic Acid Burn
Learn More
Chemotherapy helps control the growth of cancerous cells, but it may also harm healthy cells in the process. Chemocare.com reports that raised liver enzymes and low white blood cells are both common side effects of chemotherapy 6. The severity of these side effects depends on the type, dose and frequency of your chemotherapy 6. MedlinePlus reports that chemotherapy side effects typically diminish and disappear after completion of treatment 56.
Medication Complications
Certain medications cause both low white blood cells and elevated liver enzymes as side effects 2. These include:
- methotrexate
- used to treat psoriasis; asacol
- used to treat ulcerative colitis;
- clopidogrel
- commonly known as Plavix
- used to treat cardiovascular disease
If either side effect becomes serious, your physician will adjust your treatment as necessary.
Related Articles
References
- “Human Physiology: An Integrated Approach”; Dee Unglaub Silverthorn; 2006
- MayoClinic.com: Elevated Liver Enzymes; May 2011
- MedlinePlus: WBC Count; June 2011
- MedlinePlus: Cancer Chemotherapy; July 2011
- Chemocare.com: Chemotherapy Side Effects
- Ersöz G, Günşar F, Karasu Z, Akay S, Batur Y, Akarca US. Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment. Turk J Gastroenterol. 2005;16(3):124-8.
- Cusi K. Nonalcoholic fatty liver disease in type 2 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes. 2009;16(2):141-9. doi:10.1097/MED.0b013e3283293015
- Deivanayagam S, Mohammed BS, Vitola BE, et al. Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents. Am J Clin Nutr. 2008;88(2):257-62. doi:10.1093/ajcn/88.2.257
Resources
Writer Bio
Ann Jamerson began writing ads and informational brochures for research trials in 2003 during an internship at an alcohol and drug research center. She assisted in writing and editing manuscripts concerning the breast cancer genes and psychosocial effects on affected patients. She received her Bachelor of Science in biology from the University of California, San Diego and is currently attending nursing school.